In Chicago, Jeffrey Hubbell, a Professor of Molecular Engineering Innovation and Enterprise at the University of Chicago, received the Society for Biomaterials’ 2017 Founders Award. Hubbell’s immunotherapy work focuses on designing biomaterials for stimulating the immune system, fighting infections, and even shutting off some autoimmune responses that cause diseases like Type 1 diabetes. Hubbell has co-founded five companies including ClostraBio, a food allergy treatment startup, Kuros Biosciences, a developer of biomaterials technology for surgical sealants, QGel, a developer of biomaterials for cell cultures, Anokion, a developer of autoimmune technology, and Kanyos Bio, a tech developer for Type 1 diabetes and celiac disease. The award is given every year to someone who, according to the University of Chicago, has made “long-term, landmark contributions to the discipline of biomaterials.”
Home Biomaterials Society for Biomaterials Awards 2017 Founders Award to University of Chicago Professor
Latest article
Chupps commissions disappearing billboard to spotlight its biodegradable sandals
In India, footwear brand Chupps has created a sandal-shaped billboard that is made to disappear over time.
The unique advertisement, which is located in...
CJ Biomaterials to supply PHAs for biobased turf
In South Korea, CJ Biomaterials has partnered with Sweden’s BIQ Materials to produce artificial turf infill made with CJ’s PHACT™ polyhydroxyalkanoate.
Infill, commonly used...
New York “Living Room” exhibit spotlights sustainable materials in domestic design
In New York, an exhibit at Fugue Gallery is spotlighting the potential of renewable and reclaimed materials in design.
Curated by Helena Elston, Living...